EUVIMEDEUVIMED entdecken
Crossref

ATTEC-Based Autophagic Elimination of HBV Core Protein Achieves Potent Viral Suppression

Yutong Dou, Kai Tang, Baohu Li, Jing Li, Shuo Wang, Hui Xu, Shujing Xu, Kai Wang, Caiyue Ren, Yang Sun, Renhui Sun, Zhendong Fu und 6 weitere

Journal of Medicinal Chemistry · 17.11.2026

DOI: 10.1021/acs.jmedchem.6c01032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 17.11.2026. Verfasst von Yutong Dou und 17 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China, Taishan Scholar Foundation of Shandong Province, Postdoctoral Innovation Project of Shandong Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HBV core protein (HBc) plays key roles in the viral lifecycle and hepatocarcinogenesis. While core protein allosteric modulators (CpAMs) have emerged as promising therapeutic agents, they are confronted with the issue of emerging drug resistance and lack the ability to degrade HBc. To surmount these challenges, by leveraging the class II CpAM NVR3-778 and an LC3 ligand ispinesib, we identified TK-96, a first-in-class autophagy-tethering compound (ATTEC) degrader, which induces the degradation of wild-type and drug-resistant HBc via the autophagic-lysosomal pathway. Remarkably, TK-96 exhibited subnanomolar antiviral potency in HepAD38 and HBV-infected HLCZ01 cells, indicating a more than 150-fold improvement in potency compared to NVR3-778. Furthermore, oral administration of TK-96 significantly inhibited viral replication and decreased hepatic HBc, as well as serum HBeAg and HBsAg levels, in an HBV carrier mouse model. Collectively, this study identifies a highly potent HBc degrader and underscores ATTEC-mediated degradation as a novel strategy for anti-HBV therapeutics.

Förderung

  • Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China
  • Taishan Scholar Foundation of Shandong Province
  • Postdoctoral Innovation Project of Shandong Province
  • Natural Science Foundation of Shandong Province
  • Young Talent of Lifting Engineering for Science and Technology in Shandong, China
  • National Natural Science Foundation of China (NSFC)
  • Independent Project of Shandong Basic Research Special Zone (Pharmacy)
  • Shandong Basic Research Special Zone (Basic Medical Sciences)

Zitieren

APA

Dou, Y., Tang, K., Li, B., Li, J., Wang, S., Xu, H., Xu, S., Wang, K., Ren, C., Sun, Y., Sun, R., Fu, Z., Gao, L., Liang, X., Ma, C., Liu, X., Wu, Z., & Zhan, P. (2026). ATTEC-Based Autophagic Elimination of HBV Core Protein Achieves Potent Viral Suppression. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01032

Vancouver

Dou Y, Tang K, Li B, Li J, Wang S, Xu H, et al. ATTEC-Based Autophagic Elimination of HBV Core Protein Achieves Potent Viral Suppression. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01032

BibTeX
@article{Dou2026,
  author = {Dou, Yutong and Tang, Kai and Li, Baohu and Li, Jing and Wang, Shuo and Xu, Hui and Xu, Shujing and Wang, Kai and Ren, Caiyue and Sun, Yang and Sun, Renhui and Fu, Zhendong and Gao, Lifen and Liang, Xiaohong and Ma, Chunhong and Liu, Xinyong and Wu, Zhuanchang and Zhan, Peng},
  title = {ATTEC-Based Autophagic Elimination of HBV Core Protein Achieves Potent Viral Suppression},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.6c01032}
}
Kostenlos starten →